Skip to main content

Advertisement

Log in

A case report of very late stent thrombosis with peri-stent coronary artery aneurysm and stent-related coronary vasospasm

  • Case Report
  • Published:
Cardiovascular Intervention and Therapeutics Aims and scope Submit manuscript

Abstract

We describe a 42-year-old man with very late stent thrombosis (VLST) 35 months after implantation of a sirolimus-eluting stent (SES). Three months after the VLST episode, a follow-up angiography showed a formation of peri-stent coronary artery aneurysm. Sixty-five months after SES implantation, the patient suffered an out-of-hospital cardiac arrest. We performed spasm provocation test using acetylcholine to evaluate coronary vasomotor response and the coronary segments adjacent to the SES showed significant vasoconstriction. Intracoronary pretreatment of Rho-kinase inhibitor, fasudil, markedly attenuated acetylcholine-induced vasoconstriction. This report documents a unique case suffering from multiple fatal complications after SES implantation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Camenzind E, Steg PG, Wijns W. Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. Circulation. 2007;115:1440–55.

    Article  PubMed  Google Scholar 

  2. Stabile E, Escolar E, Weigold G, Weissman NJ, Satler LF, Pichard AD, et al. Marked malapposition and aneurysm formation after sirolimus-eluting coronary stent implantation. Circulation. 2004;110:e47–8.

    Article  PubMed  Google Scholar 

  3. Brott BC, Anayiotos AS, Chapman GD, Anderson PG, Hillegass WB. Severe, diffuse coronary artery spasm after drug-eluting stent placement. J Invasive Cardiol. 2006;18:584–92.

    PubMed  Google Scholar 

  4. Hofma SH, van der Giessen WJ, van Dalen BM, Lemos PA, McFadden EP, Sianos G, et al. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. Eur Heart J. 2005;27:166–70.

    Article  PubMed  Google Scholar 

  5. Aizawa K, Yasuda S, Takahashi J, Takii T, Kikuchi Y, Tsuburaya R, et al. Involvement of rho-kinase activation in the pathogenesis of coronary hyperconstricting responses induced by drug-eluting stents in patients with coronary artery disease. Circ J. 2012;76:2552–60.

    Article  PubMed  CAS  Google Scholar 

  6. Lüscher TF, Steffel J, Eberli FR, Joner M, Nakazawa G, Tanner FC, et al. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation. 2007;115:1051–8.

    Article  PubMed  Google Scholar 

  7. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation. 2004;109:701–5.

    Article  PubMed  Google Scholar 

  8. Pendyala LK, Yin LJ, Chen JP, Chronos N, Hou D. The first-generation drug-eluting stents and coronary endothelial dysfunction. J Am Coll Cardiol Intv. 2009;2:1169–77.

    Google Scholar 

  9. Shiroto T, Yasuda S, Tsuburaya R, Ito Y, Takahashi J, Ito K, et al. Role of rho-kinase in the pathogenesis of coronary hyperconstricting responses induced by drug-eluting stents in pigs in vivo. J Am Coll Cardiol. 2009;54:2321–9.

    Article  PubMed  CAS  Google Scholar 

  10. Takemoto M, Sun J, Hiroki J, Shimokawa H, Liao JK. Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase. Circulation. 2002;106:57–62.

    Article  PubMed  CAS  Google Scholar 

  11. Hiroki J, Shimokawa H, Higashi M, Morikawa K, Kandabashi T, Kawamura N, et al. Inflammatory stimuli upregulate rho-kinase in human coronary vascular smooth muscle cells. J Mol Cell Cardiol. 2004;37:537–46.

    Article  PubMed  CAS  Google Scholar 

  12. Ozaki Y, Okumura M, Ismail TF, Naruse H, Hattori K, Kan S, et al. The fate of incomplete stent apposition with drug-eluting stents: an optical coherence tomography-based natural history study. Eur Heart J. 2010;31:1470–6.

    Article  PubMed  Google Scholar 

  13. Imai M, Kadota K, Goto T, Fujii S, Yamamoto H, Fuku Y, et al. Incidence, risk factors, and clinical sequelae of angiographic peri-stent contrast staining after sirolimus-eluting stent implantation. Circulation. 2011;123:2382–91.

    Article  PubMed  CAS  Google Scholar 

  14. Kon H, Sakai H, Otsubo M, Takano H, Okamoto K, Sato T, et al. Contrast staining outside the sirolimus-eluting stent leading to coronary aneurysm formation: a case of very late stent thrombosis associated with hypersensitivity reaction. Circ Cardiovasc Interv. 2011;4:e1–3.

    Article  PubMed  Google Scholar 

  15. Kim JW, Seo HS, Park JH, Na JO, Choi CU, Lim HE, et al. A prospective, randomized, 6-month comparison of the coronary vasomotor response associated with a zotarolimus- versus a sirolimus-eluting stent: differential recovery of coronary endothelial dysfunction. J Am Coll Cardiol. 2009;53:1653–9.

    Article  PubMed  CAS  Google Scholar 

  16. Hamilos M, Sarma J, Ostojic M, Cuisset T, Sarno G, Melikian N, et al. Interference of drug-eluting stents with endothelium-dependent coronary vasomotion: evidence for device-specific responses. Circ Cardiovasc Interv. 2008;1:193–200.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Morihiko Takeda.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Takeda, M., Shiba, N., Takahashi, J. et al. A case report of very late stent thrombosis with peri-stent coronary artery aneurysm and stent-related coronary vasospasm. Cardiovasc Interv and Ther 28, 272–278 (2013). https://doi.org/10.1007/s12928-012-0155-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12928-012-0155-7

Keywords

Navigation